Reuters reporter Kate Kelland writes that MIT researchers have created a new drug-delivery capsule that can stay in the stomach for up to two weeks after being swallowed. The star-shaped device could be “a powerful weapon in fighting malaria, HIV and other diseases where successful treatment depends on repeated doses of medicine.”
MIT researchers have developed a star-shaped, drug-delivery device that can stay in the stomach for up to two weeks, gradually releasing medication, reports Melissa Healy for The Los Angeles Times. The researchers believe the device could be useful in “delivering a wide range of medications for diseases in which patient non-adherence is a problem.”
Straits Times reporter Nadia Chevroulet writes that researchers from MIT and the Singapore-MIT Alliance for Research and Technology (SMART) have uncovered how certain bacteria evade the body’s defenses. The findings could provide “new ways to counter tuberculosis, and possibly a new generation of drugs to battle antibiotic resistance.”
Ian Sample of The Guardian writes that the Human Cell Atlas project, which will be co-led by the Broad Institute, aims to map the cells in the human body . “This will have a substantial impact on our scientific understanding and as a result, on our ability to diagnose, monitor and treat disease,” says Prof. Aviv Regev.
Researchers from the Broad Institute will co-lead an initiative aimed at mapping and describing every cell in the human body, writes Kate Kelland of Reuters. "We now have the tools to understand what we are composed of, which allows us to learn how our bodies work, and uncover how all these elements malfunction in disease," explains Prof. Aviv Regev.
MIT researchers have developed a new technique to stop the spread of cancer cells through the body by delivering microRNAs to the site of the primary tumor, reports Hallie Smith for Boston Magazine. The technique “may correct gene disruptions that put a patient at risk of metastatic cancer,” Smith explains.
ABC News reporter Gillian Mohney writes that Prof. Lydia Bourouiba has captured footage of a person sneezing, showing how far sneeze droplets can travel. Bourouiba found that “large droplets tended to land within 1 to 2 meters (about 3 to 6 feet) and that small droplets could get as far as 6 to 8 meters away (19 to 26 feet).”
Prof. Lydia Bourouiba has published a new slow-motion video of a person sneezing as part of her research into how sneezes spread disease, reports Rae Ellen Bichell for NPR. Bichell explains that Bourouiba’s research is aimed at better understanding “how to prevent microbes from moving from a sick person or contaminated surface to somebody else.”
MIT researchers have developed a portable system that could produce biotech drugs on demand, reports Lisa Rapaport for Reuters. “The table-top machine has the potential to one day produce proteins to treat any number of a wide range of conditions like cancer, diabetes, heart attacks, and hemophilia,” writes Rapaport.
Prof. Susan Lindquist has been named a recipient of the Albany Medical Center Prize in Medicine and Biomedical Research, according to the AP. Lindquist’s research has raised hopes that “treatments could prevent protein ‘misfolding’ that drives degenerative conditions like Alzheimer's, Parkinson's and Lou Gehrig's disease.”
A portable device developed by MIT researchers uses programmable yeast to create drugs on demand, reports Jamie Ducharme for Boston Magazine. The device “could be a lifesaver for doctors working in vulnerable conditions, such as the battlefield, a remote village, or even an ambulance,” writes Ducharme.
Prof. Polina Anikeeva speaks with Cory Johnson of Bloomberg West about the emerging field of bioelectronics. Concerning future applications of bioelectronics, Anikeeva says that she thinks “we will start seeing more and more devices coming in and being implanted into various parts of the nervous system to treat disorders we haven’t even thought of before as neurological.”
MIT researchers have developed a programmable vaccine that could be used to respond to disease outbreaks, reports Ben Gruber for Reuters. The vaccine harnesses “messenger RNA, a genetic material that can be programmed to fight any viral, bacterial or parasitic disease by provoking an amplified immune response.”
Popular Science reporter Samantha Cole writes that MIT researchers have developed a laptop-sized, portable device that can produce biopharmaceuticals for doctors in remote locations. Cole explains that the device can “produce a single dose of treatment with a series of steps, using genetically engineered yeast cells as a mini 'factory' for a variety of customizable drugs.”
Boston Herald reporter Lindsay Kalter writes that MIT researchers have developed a portable pharmacy that can manufacture biopharmaceuticals and modify treatments. “Instead of relying on a cocktail that already exists, you can reprogram the reactor on demand to customize the treatment,” says Prof. Timothy Lu.